Lynn Silberman

549 total citations
17 papers, 498 citations indexed

About

Lynn Silberman is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Lynn Silberman has authored 17 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 4 papers in Organic Chemistry and 4 papers in Oncology. Recurrent topics in Lynn Silberman's work include Cancer therapeutics and mechanisms (12 papers), DNA and Nucleic Acid Chemistry (5 papers) and DNA Repair Mechanisms (4 papers). Lynn Silberman is often cited by papers focused on Cancer therapeutics and mechanisms (12 papers), DNA and Nucleic Acid Chemistry (5 papers) and DNA Repair Mechanisms (4 papers). Lynn Silberman collaborates with scholars based in United States and Canada. Lynn Silberman's co-authors include Leonard A. Zwelling, Elihu H. Estey, Diana Chan, Börje S. Andersson, Janice Mayes, Michael Hinds, Mark Blick, Miloslav Beran, Miloslav Beran and A.M. Zimmerman and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Lynn Silberman

17 papers receiving 478 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lynn Silberman United States 12 429 199 91 76 57 17 498
Janice Mayes United States 10 496 1.2× 301 1.5× 77 0.8× 82 1.1× 42 0.7× 17 549
Katherine L. Marsh United Kingdom 8 513 1.2× 199 1.0× 61 0.7× 113 1.5× 34 0.6× 10 576
Mauro Ponti Italy 7 329 0.8× 105 0.5× 74 0.8× 31 0.4× 14 0.2× 8 430
Krzysztof Staroń Poland 14 399 0.9× 113 0.6× 51 0.6× 41 0.5× 6 0.1× 50 490
M. D’lncalci Italy 9 256 0.6× 139 0.7× 34 0.4× 14 0.2× 79 1.4× 15 463
Chloe Stengel United Kingdom 11 271 0.6× 113 0.6× 180 2.0× 20 0.3× 12 0.2× 13 482
Sanjay Adhikari United States 13 417 1.0× 116 0.6× 37 0.4× 10 0.1× 24 0.4× 23 468
Barbara Kowalska‐Loth Poland 11 276 0.6× 62 0.3× 16 0.2× 35 0.5× 7 0.1× 25 431
Julia M. Wagner Germany 6 413 1.0× 154 0.8× 69 0.8× 6 0.1× 7 0.1× 7 523
K. Yoshihara Japan 13 620 1.4× 399 2.0× 27 0.3× 8 0.1× 8 0.1× 15 813

Countries citing papers authored by Lynn Silberman

Since Specialization
Citations

This map shows the geographic impact of Lynn Silberman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynn Silberman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynn Silberman more than expected).

Fields of papers citing papers by Lynn Silberman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynn Silberman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynn Silberman. The network helps show where Lynn Silberman may publish in the future.

Co-authorship network of co-authors of Lynn Silberman

This figure shows the co-authorship network connecting the top 25 collaborators of Lynn Silberman. A scholar is included among the top collaborators of Lynn Silberman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynn Silberman. Lynn Silberman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Zwelling, Leonard A., Michael Hinds, Diana Chan, et al.. (1989). Characterization of an Amsacrine-resistant Line of Human Leukemia Cells. Journal of Biological Chemistry. 264(28). 16411–16420. 159 indexed citations
2.
Zwelling, Leonard A., Peter G. Sacks, Waun Ki Hong, et al.. (1989). Effect of retinoic acid on DNA cleavage and cytotoxicity of topoisomerase II-reactive drugs in a human head and neck squamous carcinoma cell line.. PubMed. 49(5). 1197–201. 8 indexed citations
3.
Zwelling, Leonard A., Diana Chan, Michael Hinds, Lynn Silberman, & Janice Mayes. (1988). Anion-dependent modulations of DNA topoisomerase II-mediated reactions in potassium-containing solutions. Biochemical and Biophysical Research Communications. 152(2). 808–817. 8 indexed citations
4.
Zwelling, Leonard A., Diana Chan, Michael Hinds, et al.. (1988). Effect of phorbol ester treatment on drug-induced, topoisomerase II-mediated DNA cleavage in human leukemia cells.. PubMed. 48(23). 6625–33. 32 indexed citations
6.
Estey, Elihu H., Lynn Silberman, Miloslav Beran, Börje S. Andersson, & Leonard A. Zwelling. (1987). The interaction between nuclear topoisomerase II activity from human leukemia cells, exogenous DNA, and 4′-(9-acridinylamino) methanesulfon-m-anisidide (m-AMSA) or 4-(4,6-0-ethylidene-β-D-glucopyranoside) (VP-16) indicates the sensitivity of the cells to the drugs. Biochemical and Biophysical Research Communications. 144(2). 787–793. 43 indexed citations
7.
Zwelling, Leonard A., Elihu H. Estey, Lynn Silberman, Sharon A. Doyle, & Walter N. Hittelman. (1987). Effect of cell proliferation and chromatin conformation on intercalator-induced, protein-associated DNA cleavage in human brain tumor cells and human fibroblasts.. PubMed. 47(1). 251–7. 49 indexed citations
8.
Andersson, Börje S., et al.. (1987). In vitro toxicity and DNA cleaving capacity of benzisoquinolinedione (nafidimide; NSC 308847) in human leukemia.. PubMed. 47(4). 1040–4. 33 indexed citations
9.
Zwelling, Leonard A., et al.. (1987). Topoisomerase II as a target of antileukemic drugs.. PubMed. 79–82. 8 indexed citations
10.
Wassermann, Karsten, Leonard A. Zwelling, Lynn Silberman, et al.. (1986). Effects of 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin and doxorubicin on the survival, DNA integrity, and nucleolar morphology of human leukemia cells in vitro.. PubMed. 46(8). 4041–6. 22 indexed citations
11.
Beran, Miloslav, et al.. (1986). The production of topoisomerase II-mediated DNA cleavage in human leukemia cells predicts their susceptibility to 4′-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA). Biochemical and Biophysical Research Communications. 134(2). 638–645. 36 indexed citations
12.
Zwelling, Leonard A., Lynn Silberman, & Elihu H. Estey. (1986). Intercalator-induced, toposiomerase II-mediated DNA cleavage and its modification by antineoplastic antimetabolites. International Journal of Radiation Oncology*Biology*Physics. 12(7). 1041–1047. 20 indexed citations
13.
Zwelling, Leonard A., Elihu H. Estey, Lynn Silberman, & Walter N. Hittelman. (1985). m-AMSA-induced DNA strand breaks: A potential measure of the malignant phenotype. Proceedings of the American Association for Cancer Research. 26. 3 indexed citations
14.
Zwelling, Leonard A., Lynn Silberman, & Elihu H. Estey. (1985). Biochemical basis for tumoricidal synergism between antimetabolites and DNA intercalating agents. 37(4). 187–192. 1 indexed citations
15.
Silberman, Lynn, et al.. (1974). Identification of neoplastic versus normal cells in human cervical cell culture.. PubMed. 43(5). 635–9. 26 indexed citations
16.
Zimmerman, A.M. & Lynn Silberman. (1967). Studies on incorporation of 3H-thymidine in Arbacia eggs under hydrostatic pressure. Experimental Cell Research. 46(3). 469–476. 14 indexed citations
17.
Zimmerman, A.M. & Lynn Silberman. (1965). Cell division: The effects of hydrostatic pressure on the cleavage schedule in Arbacia punctulata. Experimental Cell Research. 38(3). 454–464. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026